CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载:15/0  |  提交时间:2019/12/04
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载:38/0  |  提交时间:2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Li, X.;  Bi, L.;  Li, Y.;  He, L.;  Xu, H.
收藏  |  浏览/下载:18/0  |  提交时间:2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 页码: 227-234
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载:7/0  |  提交时间:2019/11/19
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study 期刊论文
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 卷号: 37, 期号: 2, 页码: 227-234
作者:  Bi, L.;  Li, Y.;  He, L.;  Xu, H.;  Jiang, Z.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/11


©版权所有 ©2017 CSpace - Powered by CSpace